Dr Kim Sweeny
- is notAvailable for media queries
- is notAvailable to supervise research students at VU
- is notAvailable for media queries
- is notAvailable to supervise research students at VU
Areas of expertise
- Assessment & development of new technology & innovation
- strategic analysis
Contact details
About
Dr Kim Sweeny specialises in the strategic analysis, assessment and development of innovation. He has participated in a wide range of projects in pharmaceuticals and healthcare, biotechnology, and nanotechnology.
He is engaged in long-term research on the pharmaceuticals, healthcare and the biotechnology industry in Australia and internationally, particularly in terms of the impact of regulatory and other influences on pharmaceutical pricing and demand.
Qualification
Institute
Institute for Sustainable Industries & Liveable Cities
Key publications
Journal articles
Sweeny, K., Friedman, H.S., Sheehan, P., Fridman, M. and Shi, H. 2019, A health-system based investment case for adolescent health. Journal of Adolescent Health, 65(1), (S8-S15)
Bertram, M.Y., Sweeny, K., Lauer, J.A., Chisholm, D., Sheehan, P., Rasmussen, B., Upreti, S.R., Dixit, L.P., George, K. and Deane, S. (2018), ‘Investing in non-communicable diseases: An estimation of the return on investment for prevention and treatment services’, Lancet, 4 April 2018
Patton, G.C., Olsson, C.A., Skirbekk, V., Saffery, R., Wlodek, M.E., Azzopardi, P.S., Stonawski, M., Rasmussen, B., Spry, E., Francis, K., Bhutta, Z.A., Kassebaum, N.J., Mokdad, A.H., Murray, C.J.L., Prentice, A.M., Reavley, N., Sheehan, P., Sweeny, K., Viner, R.M., Sawyer, S.M. (2018), ‘Adolescence and the next generation’, Nature, vol. 554, pp. 458-467
Sheehan, P., Sweeny, K., Rasmussen, R., Wils, A., Friedman, H.S., Mahon, J., Patton, G.C., Sawyer, S.M., Howard, E., Symons, J., Stenberg, K., Chalasani, S., Maharaj, N., Reavley, N., Shi, H., Fridman, M., Welsh, A., Nsofor, E. and Laski, L. (2017) 'Building the foundations for sustainable development: A case for global investment in the capabilities of adolescents', The Lancet, online 19 April 2017
Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P. and Saxena, S. (2016) 'Scaling-up treatment of depression and anxiety: A global return on investment analysis', Lancet Psychiatry, vol. 3, no. 5, pp. 415-424
Ten Hoppe-Bender, P., Stenberg, K. and Sweeny, K. (2016), ‘Reductions in stillbirths: More than a triple return on investment’, The Lancet, published online January 18, 2016, S0140-6736(15)01277
Stenberg, K., Axelson, H., Sheehan, P., Anderson, I., Gülmezoglu, A.M., Temmerman, M., Mason, E., Friedman, H.S., Bhutta, Z.A., Lawn, J.E., Sweeny, K., Tulloch, J., Hansen, P., Chopra, M., Gupta, A., Vogel, J.P., Ostergren, M., Rasmussen, B., Levin, C., Boyle, C., Kuruvilla, S., Koblinsky, M., Walker, N., de Francisco, A., Novcic, N., Presern, C., Jamison, D. and Bustreo, F. on behalf of the Study Group for the Global Investment Framework for Women’s Children’s Health (2014), ‘Advancing social and economic development by investing in women's and children's health: A new global investment framework’, The Lancet, 19 November, doi:10.1016/S0140-6736(13)62231-X.
Sweeny, K. (2009), ‘The impact of copayments and safety nets on PBS expenditure’, Australian Health Review, 33(2) 215-230.
View more of Dr Sweeny's publications in VU's Research Repository.